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Resolving protein mixtures using microfluidic diffu-
sional sizing combined with synchrotron radiation cir-
cular dichroism
Christian Bortolini,a,b Tadas Kartanas,a Davor Copic,c Itzel Condado Morales,a
Yuewen Zhang,a Pavan K. Challa,a Quentin A. E. Peter,a Tamas Jávorfi,d Rohanah
Hussain,d Mingdong Dong,b Giuliano Siligardi,∗d Tuomas P. J. Knowles,∗a,e and
Jérôme Charmet ∗ f
Circular dichroism spectroscopy has become a powerful tool to characterise proteins and other
biomolecules. For heterogeneous samples such as those present for interacting proteins, typically
only average spectroscopic features can be resolved. Here we overcome this limitation by using
free-flow microfluidic size separation in-line with synchrotron radiation circular dichroism to resolve
the secondary structure of each component of a model protein mixture containing monomers and
fibrils. To enable this objective, we have integrated far-UV compatible measurement chambers
into PDMS-based microfluidic devices. Two architectures are proposed so as to accommodate for
a wide range of concentrations. The approach, which can be used in combination with other bulk
measurement techniques, paves the way to the study of complex mixtures such as the ones as-
sociated with protein misfolding and aggregation diseases including Alzheimer’s and Parkinson’s
diseases.
1 Introduction
A range of biophysical tools are available to study homogeneous
biomolecule mixtures at the molecular level, but it remains ex-
tremely challenging to study heterogeneous mixtures. A particu-
larly stricking example is that of proteins associated with misfold-
ing and aggregation diseases, including Alzheimer’s and Parkin-
son’s diseases, that aggregate into molecular species of different
sizes and solubilities from the very early stages of the disease1.
Despite significant progress made in recent years, the misfolding
pathway remains difficult to fully characterise due in large part
to a lack of biophysical tools and methods to study, in molecular
detail, such mixtures in their native environment without losing
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the temporal information of the various molecular changes and
interactions.
Bulk measurement techniques such as circular dichroism
(CD)2,3, infrared (IR) spectroscopy4,5, nuclear magnetic reso-
nance (NMR)6,7 or Thioflavin T (ThT) fluorescence8–11 have
been used to study protein folding and aggregation. However,
such techniques only report on the ensemble average and there-
fore do not allow for a precise resolution of interactions and
changes at the molecular level.
Single molecule techniques, such as atomic force microscopy
(AFM)12,13, electron microscopy (EM)14,15, infrared nanospec-
troscopy16 and high resolution imaging17,18 have received a con-
siderable interest in recent years to study protein folding and ag-
gregates at the molecular level. For example AFM and Transmis-
sion Electron microscopy (TEM) are commonly used to study pep-
tide self-assembly through the mapping of sample morphology at
different aggregation stages19–21. To date, however, the level of
structural information available from such approaches has been
more limited than from bulk spectroscopy. Besides, such mea-
surement often require operation in non-native environment.
Even though conventional separation techniques, such as liq-
uid chromatography, have been combined with bulk measure-
ment techniques to resolve complex mixtures22–26 their opera-
tion usually results in a loss of the temporal information and na-
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tive environment. For example, it has been acknowledged that
the interaction with the stationary phase and the dilution of the
samples in size exclusion chromatography may modify the state
of the sample27,28.
In recent years, microfluidic approaches have opened up new
opportunities to study complex biological processes29–32. Here,
we take advantage of the laminar flow properties inherent to op-
eration in microfluidic devices to separate a complex mixture into
well-resolved size-dependent fractions, using an H-filter configu-
ration33. In brief, we flow the solution of interest containing the
protein mixture, alongside a buffer solution. The different com-
ponents of the mixture diffuse in a size-dependent manner, into
the buffer solution and the free-flowing solution is then separated
into well resolved fractions (see Fig. 1). The concentration of the
isolated fraction is obtained based on the concentration profile
(Fig. 1.c) calculated by numerically solving the problem of parti-
cles diffusing in a fully developed Poiseuille flow in a rectangular
microfluidics channel (see Calculation of the Diffusion Profile sec-
tion). The fractions are then studied with a label-free bulk mea-
surement technique, in this case synchrotron radiation circular
dichroism (SRCD), a powerful technique to study the secondary
structure of chiral molecules (see Synchrotron Radiation Circular
Dichroism section). In particular, we use the highly collimated mi-
crobeam generated at Diamond B23 beamline for SRCD34, which
enables on-chip measurement. We show that this combination
gives information that could not be obtained by studying the com-
plex mixture without separation. In particular, we demonstrate
that by excluding larger species from one fraction (fraction 2 in
Fig. 1), it is possible to resolve precisely its structure and recon-
struct the structure of the other species (fraction 2) by subtracting
the spectrum of the resolved fraction from the that of the over-
all mixture. Even though the concept proposed herein is used
with SRCD, it is can also be adapted to other bulk measurement
techniques, such as UV/Vis, IR absorption and fluorescence mi-
croscopy.
A challenge encountered in interfacing microfluidics with CD is
the incompatibility of conventional polydimethysiloxane (PDMS)
based microfluidic devices with Dd-UV measurement (see Fig.
S1†). Even though the combination of SRCD and microfluidics
has been reported previously to study protein refolding kinetics
of cytochrome C from 4M to 0.8M GuHCL35, the mixing de-
vices used in these studies were made of fused silica with the
beamlight focused on a masked slit of 60 µm x 15 mm. The
fabrication of such devices requires access to specialised micro-
fabrication equipment and expertise, which is usually not read-
ily available in conventional biophysical laboratories. Since soft-
lithography is one of the most widely used technique to fabri-
cate microfluidic devices36,37, and in an effort to make our find-
ing available to a broad scientific community, we propose here
microfluidic devices fabricated using conventional PDMS-based
soft-lithography, compatible with far-UV measurement, including
SRCD. In the manuscript, we describe proof-of-principle microflu-
idic devices based on two architectures enabling the integration
of measurement chambers of different height, thus allowing the
measurement of a wide range of concentration (see Fig. 2).
2 Materials and methods
Sample preparation
Insulin fibrils were assembled in vitro by incubating 348 µM (2
mg/ml) of bovine insulin (Sigma Aldrich) in HCl (pH 1.3) for
8 hours at 60oC on non-binding plates (half-volume, CORNING
3881). The fibril formation was evaluated using controls insulin
were incubated under the same conditions with ThT (40 µM) as
shown in Figure S2 †. The unlabelled fibrils were then sonicated
to homogenise the mixture into approximately 100 nm long fi-
bres (Fig. S3† for TEM images) and diluted in water to the de-
sired concentration. Insulin and BSA monomers (Sigma Aldrich)
were dissolved in HCl (pH 1.3) and phosphate buffer (pH 2.7)
respectively and directly diluted to the desired concentration in
water.
Synchrotron Radiation Circular Dichroism
Circular dichroism (CD), a spectroscopic technique used to probe
conformational changes of chiral molecules38 2 3 is particularly
well suited to study protein folding and aggregation. In the case
of proteins, CD is mainly employed to assess their secondary
structure and conformation by measuring the absorption of circu-
larly polarised light in the protein backbone. If the contribution
to the CD signal of the side chains is neglected, which is usually a
good approximation, information about protein folding can be ac-
curately estimated, even when analysing samples at very low con-
centration and with composite α-helical and β -sheet domains2.
The far-UV region of CD spectra (from 180 to 240 nm) exhibits
typical absorption characteristics of α-helices (190 and 208 for pi
→ pi*, 222 nm for n→ pi*) and β -sheets (195 nm for pi → pi*, 218
nm for the n → pi*). CD spectra, therefore, contain detailed in-
formation about dissymmetric characteristics of the peptide back-
bone, the challenge resides in the extraction of this information.
An excellent way to improve the CD signal-to-noise ratio, and
therefore observe even small differences in these aggregates, is to
employ synchrotron radiation as the source of UV light. Here, we
use the highly collimated micro-beam light with high photon flux,
available at Diamond B23 beamline for SRCD, since it is possible
to focus such a beam to a spot area down to 45 µm x 15 µm,
using an objective lens, onto the microfluidic channels. Besides,
the SRCD spectra can be measured at different positions along
the microfluidic channels using a motorized XY-stage.
Fabrication of the devices
Due to the strong absorption of many materials in the far-UV
range, the fabrication of microfluidic devices for SRCD measure-
ments has, to-date, been limited to fused silica devices that can
only be fabricated in specialised laboratories35 (see Fig. S1† for
a SRCD graph obtained using a conventional PDMS device). We
have overcome this problem by developing 2 new microfluidic
devices architectures fabricated using conventional PDMS-based
soft-lithography, one of the most widely used fabrication tech-
nique for microfluidic devices. We have achieved this by inte-
grating, within the microfluidic devices, measurement chambers
confined between 2 quartz slides. In order to accommodate for
2 | 1–9Journal Name, [year], [vol.],
*Fig. 1 Schematic of the measurement principle. The combination of microfluidics-based free-flow separation with bulk measurement technique enables
the study, in molecular details, of heterogeneous mixtures in their native environment while retaining the temporal information. In the manuscript we
combine diffusion-based separation with the ability to measure SRCD using the highly collimated microbeam of B23 beamline to study proteins mixtures.
(a) The complex mixture, here made up of monomers and fibrils, is flown alongside a buffer solution. The monomers, with a smaller hydrodynamic
radius, diffuse faster than the fibres, enabling the separation of the mixture into well-defined fractions that can be studied separately. (b) Sketch of the
diffusion-based separation microfluidic device and microbeam light to probe each fraction. (c) Diffusion profile of the monomers and fibrils normalised
concentrations at the end of the microfludics device diffusion length. The fractions collected depend on the hydrodynamic resistance of the separation
channels (normalised channel width).
Fig. 2 Schematic of a typical diffusion devices for the 2 architectures presented. In each case the measurement chambers are confined between
quartz windows. The masters are represented on the left and the cross-section of the resulting device is show on the right (a) Architecture 1 consists in
two-layer devices. The height of the measurement chamber (equivalent to the path length, l) can be tuned by adapting the height of each PDMS layer.
(b) Architecture 2 is based on one-master, one-layer devices. The path length, l, is defined by the height of the channels.
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measurement in a wide range of concentrations, C, we have de-
veloped 2 device architectures enabling the tuning of the path
length, l so that the absorption, A, as defined the Beer-Lambert
law: A = εlC, where ε is the molar extinction coefficient, stays
between 0.4-1.4, ideally 0.8. Typically, for a 100 µm path length,
the protein concentration should be between 0.4-0.8 mg/ml.
The first architecture consists of a two-layer device that com-
prise, at appropriate positions along the microfluidic circuit, mea-
surement chambers confined vertically between two quartz slide
windows (Fig. 2.a). The fabrication process consists in aligning
the 2 complementary PDMS devices, with channels facing out,
before plasma bonding. The connections between the 2 layers
and to the inlet and outlet ports are made using a biopsy punch.
Finally, quartz windows are plasma bonded on each side of the de-
vice to seal the channels. The second set of devices is fabricated
using a single layer architecture and a one-mould process (Fig.
2.b). The fabrication steps consist in pouring uncured PDMS in
the master mold and pressing a 5x5 mm quartz window (cut from
a quartz slide using a diamond scriber) onto the measurement
chamber area. Once the device is cured, the structured PDMS is
peeled gently, making sure the quartz window stays in place, and
the ports are punched. Finally, a quartz slide is plasma bonded
onto the device to seal the channels (see Fig. S4†). The second
architecture was also tested successfully using a 3D printed mas-
ter (see Fig. S5.a†).
Calculation of the diffusion profile
We consider particles diffusing in a fully developed flow in a rect-
angular microfluidic channel, so the problem can be simplified
by time independence and a translationally invariant flow in the
channel direction (x axis). The flow in such a channel is given by
the Poiseuille flow. From the incompressible Navier-Stokes equa-
tion:
ρ[∂tν+(ν ·∇)ν ] =−∇p+η∇2ν+ρg (1)
we apply time invariance (∂tν = 0) and translational invariance
((ν ·∇)ν = 0) to get:
η [∂ 2y +∂
2
z ]νx(y,z) = ∂xp(x) (2)
This equation can be solved analytically. The following formula-
tion of the solution is symmetrical and converges quickly39:
νx(y,z) ∝ ∑
nyodd
∑
nzodd
1
nynz
(
n2y
W 2y
+
n2z
W 2z
) sin(nypi
Wy
y
)
sin
(
nzpi
Wz
z
)
(3)
with νx the Poiseuille flow, and Wy and Wz the dimensions of the
channel in the y and z directions.
The general convection-diffusion equation for the local concen-
tration c(x,y,z) and diffusion coefficient D is given by:
∂c
∂ t
= ∇ · (D∇c)−∇ · (νc) (4)
It is similarly simplified by translationnal invariance of the flow
and time invariance::
∂xc=
D
νx
∇2c (5)
Assuming that diffusion in the x direction is negligible (D∂ 2x c
νx∂xc):
∂xc=
D
νx
(∂ 2y +∂
2
z )c (6)
This equation is numerically integrated with a trapezoid
method and Neumann boundary conditions. The space step dx
is chosen with the Courant-Friedrichs-Lewy condition :
dx=
1
2D
min(δy,δ z)2min(νx) (7)
This choice of dx means the step matrix S is independent on D
and Q, the flow rate, given by Q =
∫
dy
∫
dzνx(y,z). Defining the
dimensionless step size dx′ = dx ∗D/Q, the number of steps to
reach a position L is found to be:
Nsteps =
LD
dx′Q
(8)
The evolution of an initial concentration distribution c0 can
therefore be quickly calculated by repeated matrix squaring. In-
deed using Si = S2
i
, only at most log2(Nsteps) matrix multipli-
cations are necessary. For example 50 is 110010 in binary, so
c50 = S6 · (S5 · (S1 · c0)). Figure S6† shows concentration profiles
obtained using the above for insulin monomers.
3 Results and discussions
3.1 Validation using simple solutions
In order to validate the compatibility of the two device archi-
tectures with SRCD, we have proceeded to a range of exper-
iments using model protein systems. BSA monomers and in-
sulin monomers and amyloid fibrils formed from the same pro-
teins40,41 were tested in a range of microfluidic devices under
flow and static conditions and compared with the spectra ob-
tained in static mode in dedicated flow cells, using both SRCD
and a bench top CD spectropolarimeter Chirascan Plus.
In the first set of separation experiments, solutions of insulin
monomers (0.2 mg/ml) or fibres (0.4 mg/ml) were injected
alongside a buffer solution (water) and SRCD spectra were mea-
sured in the two measurement chambers, each collecting 50% of
the solution, after a diffusion length of 90 mm (Fig 3.a). The
high diffusion chamber collects a fraction of the small, high diffu-
sion coefficient molecules, while the low diffusion measurement
chambers retains most of the larger molecules, with a lower dif-
fusion coefficient (Fig 3.a,b). The flow rates were 30 and 300
µl/h for the insulin and the buffer solutions respectively. The
devices were made using the first architecture and the heights
of the measurement chambers, corresponding to the path length,
ranged typically between 3 and 5 mm. The spectra obtained for
the monomers, with a typical high α-helical content (see Fig. 3.c),
and fibres, with a stronger β -sheet signal (see Fig. S7†), are in
good agreement with the results obtained using benchtop CD in-
strument in static mode and confirm that neither the devices, nor
the flow rate, induce any artefact (see Fig. S8† for the spectra
and secondary structure of undiluted solutions using a benchtop
4 | 1–9Journal Name, [year], [vol.],
Fig. 3 Validation of the diffusion based separation using simple solutions of insulin monomers. (a) Simplified sketch of the device used with indication
of the low (black circle) and high (grey circle) diffusion chambers. (b) Diffusion profile and fractions collected at the end of the diffusion channel. (c)
SRCD spectra of insulin monomer in each chamber.
Fig. 4 Concentration profile of a solution of insulin monomers (2 mg/ml) across a 2000 µm wide microfluidic channel with flow rates of 30 and 300 µ l/h
for the monomers and buffer solution respectively. The high energy photon beam was positioned using the motorised stage in 5 locations across the
channel and the SRCD signal amplitude, taken at 208 nm, was measured continuously during one minute and averaged. The measured profile shows
a good agreement with the expected (simulated) profile.
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CD instrument).
Table 1 Comparison between expected (calculated) and measured frac-
tion of insulin monomer and fibres in each chamber. A reference value of
208 nm was chosen for the monomers as it corresponds to the pi → pi*
excitonic transition of α-helices; 222 nm is representative of the n → pi*
of β -sheet rich compounds such as insulin fibres.
Measured Calculated
Amyloid fibrils (222 nm) 2.3 % 1.1 %
Monomers (208 nm) 13.8 % 11.7 %
In order to verify the efficiency of the diffusion-based separa-
tion, we have measured the concentration of each fraction and
compared it with the expected theoretical value. The concen-
tration ratios were measured by dividing the amplitude of the CD
signal at 208 nm (monomer) and 222 nm (fibre) in each chamber
by the corresponding amplitude of the total concentration. These
values were compared to the concentration expected due to diffu-
sion, as calculated using the area under the theoretical concentra-
tion profile (Fig. 3.b). The measured and expected (calculated)
fraction in each chamber show excellent agreement as detailed in
Table 1.
Fig. 5 Time-dependent measurements. SRCD spectra of BSA protein
(initial concentration 0.3 mg/ml) in a dilution experiment as a function of
time. In this case, the channel is initially loaded with the sample solution
and the buffer is introduced progressively at 30 µ l/ in a Y-junction mi-
crofluidic device fabricated by soft-lithography using a 3D printed master
mould.
We also measured the concentration profile of a solution of in-
sulin monomers (2 mg/ml) across a 2000 µm wide microfluidic
channel, using the second architecture with a 50 µm high chan-
nel, and flow rates of 30 and 300 µl/h for the monomers and
buffer solution respectively. The SRCD signal amplitude at 208
nm was measured continuously for 1 minute in 5 positions across
the channel width. The normalised average amplitude points
(and standard deviation) show a good match with the expected
concentration profile as shown in Figure 4.
Finally, we performed a time-dependent dilution experiment,
using BSA (0.2 mg/ml, 60 µl/h) in a Y-junction channel fabri-
cated with a 3D printed master mould based on the second archi-
tecture. The measurement, limited by the time needed to acquire
a full spectrum, is performed at the end of the channel, across
its entire width, where the original sample gets diluted due to
the progressive introduction of the aqueous buffer solution from
0 µl/h to 60 µl/h. The spectra shown in Figure 5) do not exhibit
any distortions, as confirmed after normalisation (Fig. S5.b†). For
faster experiments, continuous measurement at a single wave-
length can be performed.
The validation results presented above, obtained using simple
protein solutions, constitute a proof that the different microflu-
idics device architectures proposed are compatible with SRCD.
3.2 Resolution in complex mixtures
Finally, we explore the possibility to resolve complex protein mix-
tures using the methods and devices detailed earlier. To this ef-
fect, we explored solutions comprised of insulin monomers and
fibrils, mixed at different concentrations depending on the de-
vices used. The case of a microfluidic device of 25 µm path length
used to resolve a 1:1 mixture of monomers (3 mg/ml) and fibrils
(1 mg/ml) is shown in Fig. 6. By analysing the spectrum of the
mixture and calculating the secondary structures, it is not possi-
ble to resolve the different fractions that compose it, without an a
priori knowledge of the individual fractions. However, if one can
isolate a single constituent it then becomes possible to resolve the
mixture. The case of a 2 component mixture is straight forward
and is demonstrated experimentally in this manuscript (Fig. 6).
The case of more complex mixtures is discussed later.
Using the H-filter microfluidic separation device architecture
presented herein, we isolate a fraction of monomers from the mix-
ture. Using an 18 cm long diffusion channel, one can direct 22 %
of monomers and no fibres (0 %) in the high-diffusion chamber
by collecting one third of the flow (see Fig 6.a, right hand-side
spectrum). The amplitude of the spectrum collected is then ad-
justed by a multiplication factor (in this case, 100/22 = 4.55) to
account for the 100 % of monomer present in the mixture and
subtracted from the spectrum obtained for the mixture. The re-
sulting reconstructed spectrum, shown in Figure 6.c, compares
well with the spectrum of a fibril solution (of the same concen-
tration) measured in the same chamber. This observation is con-
firmed by the analysis of the secondary structure, calculated using
BeStSel, a method for the secondary structure determination and
fold recognition from protein circular dichroism spectra42. Fig-
ure 6.d shows that the α-helical content for the reconstructed and
measured spectra are identical (6 and 7 % for the reconstructed
and measured spectra respectively). The β -sheet and unordered
contents, however, show small discrepancies. The β -sheet con-
tent is of 36 % for the reconstructed and 42 % for the measured
spectra while the unordered content is of 42 and 38 % for the
reconstructed and measured spectra respectively. The differences
observed can be attributed to small distortions of the spectrum
that can arise due to variation of the microfluidics chip position
with respect to the photon beam between the measurements, the
measurement in dynamic mode and resulting flow fluctuations, as
well as the low concentration collected, imposed by the necessity
to exclude fibres from the high-diffusion chamber. It is noted also
that even though monomers are stable at room temperature and
neutral pH, they can start to aggregate with the fibrils, which act
6 | 1–9Journal Name, [year], [vol.],
Fig. 6 Resolution of mixtures of insulin monomer and fibrils using analytical diffusion-based microfluidics separation and SRCD. It is not possible to
resolve the mixture from its SRCD spectrum (a, left). However, by isolating the monomers (a, right), it is possible to reconstruct the fibrils spectrum
after subtracting the spectrum of the resolved fraction from the that of the total mixture. (b). The spectrum shows good agreement with the measured
spectrum in the same conditions (b) as confirmed by the analysis of their secondary structures (c).
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as catalysts43. However, in this case, such conversion is very slow
and, therefore, the content of the solutions studied is expected
to be stable for the duration of the experiments presented herein
(see Fig. S9† for details).
The approach described above can also be adapted to resolve
more complex mixtures. Microfluidic diffusion-based separation
enables the exclusion of species above a given hydrodynamic ra-
dius, in a single separation step. Even though it would theoreti-
cally be possible to isolate the smallest molecule in the complex
mixture (e.g. a monomer), it has been shown that it is not pos-
sible to precisely resolve biomolecules unless their hydrodynamic
radii differ by at least a factor three44. Therefore, in order to
increase the separation resolution, one should combine the ap-
proach with other high resolution microfluidic separation tech-
niques, such as free-flow electrophoresis that enabsle the selec-
tion of biomolecules based on their electrophoretic mobility45–47.
However, ultimately, the detection of a single constituent from
a mixture will be limited by the sensitivity of the measurement
technique. Nevertherless, the separation of a heterogeneous mix-
ture into less complex, yet well-resolved, fractions is expected to
provide further insights into complex biological phenomena.
4 Conclusions
The study of heterogeneous mixtures of proteins is challenging
yet important for a number of practical applications. Current
biophysical methods and devices are usually not well-suited to
study, in molecular details, heterogeneous mixtures in their na-
tive environment while retaining the temporal information. In
this manuscript, we show that the combination of microfluidic
free-flow separation and label-free bulk measurement techniques
such as synchrotron radiation circular dichroism can overcome
such issues. In particular, we demonstrate that a diffusional siz-
ing microfluidic device can be used to isolate into a well-resolved
fraction, insulin monomers from a heterogeneous mixture of in-
sulin monomers and fibrils. Using the spectrum from this fraction,
it is possible to extract information about the missing fraction and
finally resolve the entire heterogeneous mixture.
In order to make the results presented in this study available
to a broad scientific community, we have developed new fabrica-
tion methods to integrate far-UV compatible measurement cham-
bers (confined between quartz windows) into PDMS based mi-
crofluidic devices fabricated using conventional soft-lithography
approaches. Two device architectures, which enable the mea-
surement of a wide range of concentrations, are presented, char-
acterised and validated using the highly collimated and high
photon-flux microbeam light available at Diamond Light Source
B23 beamline for SRCD.
The device architecture presented herein can also be used in
combination with other sensing modalities requiring far-UV trans-
parency and more generally, the principle can also be adapted to
other bulk measurement techniques. In summary, the possibility
to precisely separate a heterogeneous mixture into well-resolved,
simpler fractions opens up a range of opportunities for the study
of complex biological phenomena. In particular, such develop-
ments open up interesting perspective to study protein misfold-
ing and aggregation diseases such as Alzheimer’s and Parkinson’s
diseases and may provide time-resolved information about the
protein aggregation pathway.
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